Top

Published in:

01-02-2020 | Glioma | Original Article

Machine learning-based quantitative texture analysis of conventional MRI combined with ADC maps for assessment of IDH1 mutation in high-grade gliomas

Authors: Deniz Alis, Omer Bagcilar, Yeseren Deniz Senli, Mert Yergin, Cihan Isler, Naci Kocer, Civan Islak, Osman Kizilkilic

Published in: Japanese Journal of Radiology | Issue 2/2020

Abstract

Purpose

To assess the performance of texture analysis of conventional magnetic resonance imaging (MRI) and apparent diffusion coefficient (ADC) maps in predicting IDH1 status in high-grade gliomas (HGG).

Materials and methods

A total of 142 patients with HGG were included in the study. IDH1 mutation was present in 48 of 142 HGG (33.8%). Patients were randomly divided into the training cohort (n = 96) and the validation cohort (n = 46). Texture features were extracted via regions of interest on axial T2WI FLAIR, post-contrast T1WI, and ADC maps covering the whole volume of the tumors. The training cohort was used to train the random forest classifier, and the diagnostic performance of the pre-trained model was tested on the validation cohort.

Results

The random forest model of conventional MRI sequences and ADC images achieved diagnostic accuracy of 82.2% and 80.4% in predicting IDH1 status in the validation cohorts, respectively. The combined model of T2WI FLAIR, post-contrast T1WI, and ADC images exhibited the highest diagnostic accuracy equating 86.94% in the validation cohort.

Conclusion

Texture analysis of conventional MRI sequences enhanced by ML analysis can accurately predict the IDH1 status of HGG. Adding textural analysis of ADC maps to conventional MRI results in incremental diagnostic performance.

Available only for authorised users

Weller M, van den Bent M, Tonn JC, Stupp R, Preusser M, Cohen-Jonathan-Moyal E, et al. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. Lancet Oncol. 2017;18:e315–29. https://doi.org/10.1016/S1470-2045(17)30194-8.CrossRefPubMed

Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization Classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803–20. https://doi.org/10.1007/s00401-016-1545-1.CrossRefPubMed

Weller M, Pfister SM, Wick W, Hegi ME, Reifenberger G, Stupp R. Molecular neuro-oncology in clinical practice: a new horizon. Lancet Oncol. 2013;14:e370–9. https://doi.org/10.1016/S1470-2045(13)70168-2.CrossRefPubMed

Song Tao Q, Lei Y, Si G, Yan Qing D, Hui Xia H, Xue Lin Z, et al. IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma. Cancer Sci. 2012;103:269–73. https://doi.org/10.1111/j.1349-7006.2011.02134.x.CrossRef

Ellingson BM. Radiogenomics and imaging phenotypes in glioblastoma: novel observations and correlation with molecular characteristics. Curr Neurol Neurosci Rep. 2015;15:506. https://doi.org/10.1007/s11910-014-0506-0.CrossRefPubMed

Qi SS, Yu L, Li H, Ou Y, Qiu X, Ding Y, et al. Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms. Oncol Lett. 2014;7:1895–902.CrossRefPubMedPubMedCentral

Metellus P, Coulibaly B, Colin C, de Paula AM, Vasiljevic A, Taieb D, et al. Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis. Acta Neuropathol. 2010;120:719–29. https://doi.org/10.1007/s00401-010-0777-8.CrossRefPubMed

Kickingereder P, Sahm F, Radbruch A, Wick W, Heiland S, Deimling AV, et al. IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non invasively predictable with rCBV imaging in human glioma. Sci Rep. 2015;5:16238. https://doi.org/10.1038/srep16238.CrossRefPubMedPubMedCentral

Biller A, Badde S, Nagel A, Neumann JO, Wick W, Hertenstein A, et al. Improved brain tumor classification by sodium MR imaging: prediction of IDH mutation status and tumor progression. AJNR Am J Neuroradiol. 2016;37:66–73. https://doi.org/10.3174/ajnr.A4493.CrossRefPubMedPubMedCentral

10.

Pope WB, Prins RM, Albert Thomas M, Nagarajan R, Yen KE, Bittinger MA, et al. Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy. J Neurooncol. 2012;107:197–205. https://doi.org/10.1007/s11060-011-0737-8.CrossRefPubMed

11.

Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2015;278:563–77. https://doi.org/10.1148/radiol.2015151169.CrossRefPubMed

12.

van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77:e104–7. https://doi.org/10.1158/0008-5472.CAN-17-0339.CrossRefPubMedPubMedCentral

13.

Park YW, Han K, Ahn SS, Bae S, Choi YS, Chang JH, et al. Prediction of IDH1-mutation and 1p/-19q-codeletion status using pre-operative MR imaging phenotypes in lower grade gliomas. AJNR Am J Neuroradiol. 2018;39:47. https://doi.org/10.3174/ajnr.A5421.CrossRef

14.

Li Z, Wang Y, Yu J, Guo Y, Cao W. Deep learning based radiomics (DLR) and its usage in non-invasive IDH1 prediction for low grade glioma. Sci. Rep. 2017;7:5467. https://doi.org/10.1038/s41598-017-05848-2.CrossRefPubMedPubMedCentral

15.

Yu J, Shi Z, Lian Y, Li Z, Liu T, Gao Y, et al. Non-invasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma. Eur Radiol. 2017;27:3509–22. https://doi.org/10.1007/s00330-016-4653-3.CrossRefPubMed

16.

Zhang B, Chang K, Ramkissoon SS, Tanguturi S, Bi WL, Reardon DA, et al. Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas. Neuro Oncol. 2017;19:109–17. https://doi.org/10.1093/neuonc/now121.CrossRefPubMed

17.

Sonoda Y, Shibahara I, Kawaguchi T, Saito R, Kanamori M, Watanabe M, et al. Association between molecuar alterations and tumor location and MRI characteristics in anaplastic gliomas. Brain Tumor Pathol. 2015;32:99–104. https://doi.org/10.1007/s10014-014-0211-3.CrossRefPubMed

18.

Yamashita K, Hiwatashi A, Togao O, Kikuchi K, Hatae R, Yoshimoto K, et al. MR imaging-based analysis of glioblastoma multiforme: estimation of IDH1 mutation status. AJNR Am J Neuroradiol. 2016;37:58–65. https://doi.org/10.3174/ajnr.A4491.CrossRefPubMedPubMedCentral

19.

Reuss DE, Sahm F, Schrimpf D, Wiestler B, Capper D, Koelsche C, et al. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta Neuropathol. 2015;129:133–46. https://doi.org/10.1007/s00401-014-1370-3.CrossRefPubMed

20.

Shafiq-Ul-Hassan M, Zhang GG, Latifi K, Ullah G, Hunt DC, Balagurunathan Y, et al. Intrinsic dependencies of CT radiomic features on voxel size and number of gray levels. Med Phys. 2017;44:1050–62. https://doi.org/10.1002/mp.12123.CrossRefPubMed

21.

Szczypiński PM, Klepaczko A. MaZda-A Framework for biomedical image texture analysis and data exploration. Biomed Texture Anal. 2017;315–47.

22.

Thibault G, Fertil B, Navarro C, Pereira S, Cau P, Levy N, et al. Texture indexes and gray level size zone matrix application to cell nuclei classification. Pattern Recogn Inform Process. 2009;140–5.

23.

Mao J, Jain AK. Texture classification and segmentation using multiresolution simultaneous autoregressive models. Pattern Recogn. 1992;25:173–88.CrossRef

24.

Frank E, Hall AM, Witten I. The WEKA Workbench. Online Appendix for “Data mining: practical machine learning tools and technique”, Morgan Kaufmann, 4th edn., 2016.

25.

Breiman L. Random forests. Mach Learn. 2001;45:5–32.CrossRef

26.

Arlot S, Celisse A. A survey of cross-validation procedures for model selection. Stat Surv. 2010;4:40–79.CrossRef

27.

Kocak B. Durmaz ES, Ates E, Kilickesmez O. Radiomics with artificial intelligence: a practical guide for beginners. Diagn Interv Radiol. https://doi.org/10.5152/dir.2019.19321.CrossRefPubMedPubMedCentral

28.

Bisdas S, Shen H, Thust S, Katsaros V, Stranjalis G, Boskos C, et al. Texture analysis-and support vector machine-assisted diffusional kurtosis imaging may allow in vivo gliomas grading and IDH-mutation status prediction: a preliminary study. Sci Rep. 2018;8:6108. https://doi.org/10.1038/s41598-018-24438-4.CrossRefPubMedPubMedCentral

29.

Han L, Wang S, Miao Y, Shen H, Guo Y, Xie L, et al. MRI texture analysis based on 3D tumor measurement reflects the IDH1 mutations in gliomas—a preliminary study. Eur J Radiol. 2019;112.169–179. https://doi.org/10.1016/j.ejrad.2019.01.025.CrossRefPubMed

30.

Su CQ, Lu SS, Zhou MD, Shen H, Shi HB, Hong XN. Combined texture analysis of diffusion-weighted imaging with conventional MRI for non-invasive assessment of IDH1 mutation in anaplastic gliomas. Clin Radiol. 2019;74:154–60. https://doi.org/10.1016/j.crad.2018.10.002.CrossRefPubMed

31.

Lewis MA, Ganeshan B, Barnes A, Bisdas S, Jaunmuktane Z, Brandner SS, et al. Filtration-histogram based magnetic resonance texture analysis (MRTA) for glioma IDH and 1p19q genotyping. Eur J Radiol. 2019;113:116–23. https://doi.org/10.1016/j.ejrad.2019.02.014.CrossRefPubMed

32.

Zhou H, Chang K, Bai HX, Xiao B, Su C, Bi WL, et al. Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low-and high-grade gliomas. J Neurooncol. 2019;142:299–307. https://doi.org/10.1007/s11060-019-03096-0.CrossRefPubMedPubMedCentral

33.

Balagurunathan Y, Kumar V, Gu Y, Kim J, Wang H, Liu Y, et al. Test–retest reproducibility analysis of lung CT image features. J Digit Imaging. 2014;27:805–23. https://doi.org/10.1007/s10278-014-9716-x.CrossRefPubMedPubMedCentral

Title: Machine learning-based quantitative texture analysis of conventional MRI combined with ADC maps for assessment of IDH1 mutation in high-grade gliomas
Authors: Deniz Alis
Omer Bagcilar
Yeseren Deniz Senli
Mert Yergin
Cihan Isler
Naci Kocer
Civan Islak
Osman Kizilkilic
Publication date: 01-02-2020
Publisher: Springer Japan
Keywords: Glioma
Magnetic Resonance Imaging
Magnetic Resonance Imaging
Glioma
Glioma
Published in: Japanese Journal of Radiology / Issue 2/2020
Print ISSN: 1867-1071
Electronic ISSN: 1867-108X
DOI: https://doi.org/10.1007/s11604-019-00902-7

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Machine learning-based quantitative texture analysis of conventional MRI combined with ADC maps for assessment of IDH1 mutation in high-grade gliomas

Abstract

Purpose

Materials and methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2020

CT diagnosis of non-traumatic gastrointestinal perforation: an emphasis on the causes

Early volume reduction of the hippocampus after whole-brain radiation therapy: an automated brain structure segmentation study

Prevalence of extracardiac findings in patients undergoing coronary computed tomography and additional low-dose whole-body computed tomography

Characteristics of cerebral perfusion and diffusion associated with crossed cerebellar diaschisis after acute ischemic stroke

Relationship between the degree of abdominal wall movement and the image quality of contrast-enhanced MRI: semi-quantitative study especially focused on the occurrence of transient severe motion artifact

Analysis of CT characteristics in the diagnosis of Schistosoma japonicum associated appendicitis with clinical and pathological correlation: a diagnostic accuracy study